28 April 2014

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology announces that, in the six months since the previous block admission update in October 2013 the following changes have taken place:

Futura Medical plc Option Plan Block Listed
Block Listing Brought Forward Options Exercised in Period Re-classified Block Listing
Carried Forward
Unapproved Share Option Scheme 2,008,383 1,878,114 (100,000) 8,321 1,786,435
EMI Share Option Scheme 2,996,617 1,889,127 (52,500) (8,321) 1,828,306
  5,005,000 3,767,241 (152,500) - 3,614,741


For further information please contact:

Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670

Nominated Adviser:
N+1 Singer
Aubrey Powell / Liz Yong / Thomas Smale
Tel: +44 (0) 20 7496 3000

For media enquiries please contact:

Buchanan Communications Limited
Mark Court / Sophie Cowles /
Stephanie Watson
Tel: +44 (0) 20 7466 5000


Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.